top of page

Client Stories & Insights

Case Studies

Agentic AI-led Clinical Study Report (CSR) creation - with extension opportunity for many of the eCTD dossier documents

CSR creation requires 40-60% manual effort from domain functional team that can be automated using AI.  We developed a Human-In-The-Loop workflow in collaboration with medical writing and AI technical team that leverages agentic AI to create CSR.  The productized solution is aligned with FDA requirements for AI-led submissions.  The approach is being extended to cover some of the other documents that are part of eCTD.

Case Studies

Case Studies

Private equity asset valuation and due diligence

Evaluation of Mid-market CRO Investments for a Private Equity Firm

We advised our Private Equity firm client on the market landscape of CROs and FSP service providers (clinical data sciences, regulatory and clinical operations) and evaluation of investments in data driven CRO assets.  

Interested in discussing how LS-SACS can assist in your holistic digital transformation strategy and improved outcomes?

Case Studies

Case Studies

Digital clinical SaaS platforms with AI

Go To Market strategy and Funding Pitch for an AI / ML based clinical SaaS provider for DCT, hybrid and virtual trials

We advised a clinical SaaS company with their product, solutions, leadership structure and Go To Market strategy, and pitch for seeking Venture Capital Funding

Case Studies

Insights

Insights

Acelerating holistic digital transformation

Accelerating AI-driven digital transformation Through a Holistic Approach 

How to Ensure Competitive Advantage Through Strategic Sourcing and Outsourcing 

Digital clinical maturity assessment

The article describes how life sciences companies need to design and implement "Holistic Digital Transformation" programs to realize tangible and meaningful outcomes. 

Insights

How to Achieve Clinical Sourcing Objectives with a Service Management Group (SMG)

growth and transformation strategy

While it is important to focus on the outsourcing process (RFX), pricing, and contract negotiations, it is also critical to design and develop an internal, dedicated Service Management Group (SMG) to ensure that the transformational benefits of the sourcing program are realized. 

collaboration and true partnership

How can life sciences companies continue to maintain sustainable competitive advantage by  leveraging suppliers & partners to achieve their innovation and transformation objectives?

Insights

Utilizing Functional Service Provider (FSP) Model for Sourcing Clinical, PV, Regulatory or other Services

Digital clinical
Clinical trials

Functional Service Provider (FSP) models that can cover clinical operations, clinical data services (CDM, Biostatistics), regulatory, safety or other areas meet a critical need life sciences companies and can be established in a variety of engagement models.  The article provides some of the best practices for a successful FSP strategy and ensure realization of planned benefits / outcomes.

Insights

Best Practices for Leveraging CRO / FSP Partnerships to fit  "Future-Ready" Operating Models of Life Sciences Companies

LS-SACS partnership

Nearly 70% of R&D budget is spent on clinical trials and CRO partnerships It is imperative that life sciences companies have a dependable set of global and regional external partnerships that are flexible and scalable and whose capabilities fit well with the pharmaceutical companies' growth strategy.  This article covers some of the best practices that life sciences companies can adopt to realize the full benefits of such partnerships.

Interested in discussing some of the evolving Best Practices followed by your peers in the Life Sciences industry ?  

bottom of page